RNAC - Cartesian Therapeutics, Inc.

📈 Is growth accelerating? 7 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Mar 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2014 10-K ↗	Q1 FY2016 Dec 31, 2014 10-K ↗	Q4 FY2015 Dec 31, 2013 10-K ↗
Revenue Growth YoY (%)	-92.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1261%)	N/M	16.8% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+110%)	-99.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1339%)	-81.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1115%)	N/M	-94.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1276%)	537.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6615%)	-1.7% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-121%)	-50.8% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-735%)	-68.4% Weak → Weak Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-955%)	-86.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1183%)	-82.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1132%)	-43.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-649%)	-15.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-290%)	99.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1147%)	207.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2496%)	150.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1781%)	425.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5222%)	—	—	79.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+895%)	—	N/M	N/M	39041.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+487915%)	—	—	—	-87.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1195%)	N/M	N/M	N/M	—	—	—	—	—	—	—
EPS Growth YoY (%)	-114.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	-22.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-12.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	93.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	37.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	-149.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	-20.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	-75.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	68.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	N/M	-77.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-121.2% Weak ↑ Weak Improving Year-over-year change in net income	-802.9% Weak ↓ Weak Declining Year-over-year change in net income	68.8% Excellent ↓ Excellent Declining Year-over-year change in net income	68.8% Excellent ↑ Excellent Improving Year-over-year change in net income	68.8% Excellent ↑ Excellent Improving Year-over-year change in net income	94.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-162.3% Weak → Weak Stable Year-over-year change in net income	-162.3% Weak Weak Year-over-year change in net income	-162.3% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	N/M	-51.9% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	N/M	-25.4% Weak ↓ Weak Declining Year-over-year change in net income	-25.4% Weak ↑ Weak Improving Year-over-year change in net income	-25.4% Weak ↑ Weak Improving Year-over-year change in net income	-3.7% Weak ↑ Weak Improving Year-over-year change in net income	-62.5% Weak ↓ Weak Declining Year-over-year change in net income	-62.5% Weak ↓ Weak Declining Year-over-year change in net income	-62.5% Weak ↓ Weak Declining Year-over-year change in net income	23.8% Good → Good Stable Year-over-year change in net income	24.0% Good ↑ Good Improving Year-over-year change in net income	24.0% Good ↑ Good Improving Year-over-year change in net income	24.0% Good ↑ Good Improving Year-over-year change in net income	-29.1% Weak ↓ Weak Declining Year-over-year change in net income	-8.3% Weak ↓ Weak Declining Year-over-year change in net income	0.5% Caution Caution Year-over-year change in net income	-5.0% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	11.6% Fair Fair Year-over-year change in free cash flow	—	—	—	69.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-75.2% Weak Weak Year-over-year change in free cash flow	—	—	—	41.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-76.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-61.7% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-72.1% Weak → Weak Stable Compound annual revenue growth over 3 years	-80.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-68.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	—	-74.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	19.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-19.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-11.6% Weak Weak Compound annual revenue growth over 3 years	12.1% Good Good Compound annual revenue growth over 3 years	—	—	36.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	—	1345.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	1403.7% Excellent Excellent Compound annual revenue growth over 3 years	1107.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	343.5% Excellent Excellent Compound annual revenue growth over 3 years	456.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-62.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-39.8% Weak Weak Compound annual revenue growth over 5 years	-37.3% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	380.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	257.5% Excellent Excellent Compound annual revenue growth over 5 years	244.6% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	161.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	277.5% Excellent → Excellent Stable Compound annual revenue growth over 5 years	332.3% Excellent Excellent Compound annual revenue growth over 5 years	201.3% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	—	-34.3% Weak Weak Compound annual EPS growth over 3 years	—	-67.0% Weak Weak Compound annual EPS growth over 3 years	—	-21.5% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Mar 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2014 10-K ↗	Q1 FY2016 Dec 31, 2014 10-K ↗	Q4 FY2015 Dec 31, 2013 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	41.1% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+174%)	-228.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1624%)	-439.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3030%)	-199.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1430%)	-355.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2467%)	-309.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2164%)	-50.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-437%)	-7.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-151%)	35.3% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+135%)	31.7% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+111%)	13.6% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-9%)	-8.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-154%)	2.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-85%)	-64.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-532%)	-66.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-541%)	-295.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2071%)	—	—	-188.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1359%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-5.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	1.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-766.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	-169.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1516%)	—	—	-330.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2856%)	-412.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3539%)	-364.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3140%)	35.1% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+192%)	—	73.3% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+511%)	84.6% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+605%)	40.9% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+241%)	-100.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-939%)	-125.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1142%)	-222.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1955%)	-129.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1177%)	-422.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3619%)	—	—	-223.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1965%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	-282.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-282.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-149.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-71.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-36.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-106.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-44.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-110.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-62.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-194.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.57x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.20x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.37x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.29x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.13x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.41x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-2.05x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	-0.43x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-2.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.44x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.49x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-3.33x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.68x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-1.36x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	-1.08x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.02x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Mar 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2014 10-K ↗	Q1 FY2016 Dec 31, 2014 10-K ↗	Q4 FY2015 Dec 31, 2013 10-K ↗
Return on Invested Capital (%)	14.1% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	49.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	46.4% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	681.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	79.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	310.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-1846.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	9.0% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	6.5% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-22.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	12.2% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	15.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	17.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	91.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	28.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	43.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	186.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	99.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	169.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-118.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	-231.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-170.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-68.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	-16.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-28.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-9.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-5.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	4.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-12.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	7.4% Fair Fair Operating profit relative to total assets Optimal: > 10%	7.4% Fair Fair Operating profit relative to total assets Optimal: > 10%	—	—	0.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-4.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-21.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	35.6% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—	—	-15.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-12.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-20.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	26.5% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+76%)	73.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+389%)	49.4% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+229%)	—	81.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+442%)	150.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+905%)	—	56.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+273%)	48.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+224%)	40.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+169%)	-35.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-339%)	-33.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-321%)	-29.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-294%)	6.3% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-58%)	33.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+126%)	32.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+114%)	51.6% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+244%)	54.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+262%)	131.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+775%)	—	125.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+738%)	85.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+472%)	265.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1672%)	150.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+902%)	223.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1393%)	-177.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1282%)	—	—	—	—	-214.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1531%)	-73.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-589%)	-30.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-304%)	—	-22.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-250%)	-20.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-236%)	-36.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-346%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Mar 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2014 10-K ↗	Q1 FY2016 Dec 31, 2014 10-K ↗	Q4 FY2015 Dec 31, 2013 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	-10.26x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-24.78x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-22.75x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-10.53x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.99x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	19.38x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	15.24x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	5.74x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	-2.77x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	0.64x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.07x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-37.63x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-79.84x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-68.95x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-37.52x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-30.40x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-40.59x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-29.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	102.94x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-41.51x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-51.42x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-45.18x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	190.13x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-51.69x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-56.89x Weak Weak Operating income divided by interest expense Optimal: > 5x	-49.27x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-118.64M	$-125.14M	$-143.38M	$-160.32M	$-180.43M	$-212.61M	$-219.20M	$-87.23M	$-103.42M	$-76.91M	$-79.60M	$-112.03M	$-125.92M	$-106.44M	$-112.84M	$-138.06M	$-113.44M	$-114.06M	$-114.64M	$-125.75M	$-125.41M	$-138.69M	$-146.26M	$-59.73M	$-72.61M	$-89.89M	—	—	—	$-37.40M	$-50.48M	$-60.24M	$-58.23M	—	$-72.15M	$-82.63M	$-32.34M	$-16.59M	$-16.59M	$-8.06M

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Mar 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2014 10-K ↗	Q1 FY2016 Dec 31, 2014 10-K ↗	Q4 FY2015 Dec 31, 2013 10-K ↗
Revenue per Share (USD)	$0.00	—	$0.02	$0.01	$0.04	—	$0.02	$2.00	$1.08	—	$1.27	$1.03	$1.16	—	$4.07	$7.94	$8.22	—	$6.37	$5.20	—	—	$1.32	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.46	$-3.57	$-1.38	$0.51	$-0.68	$0.13	$-1.13	$0.58	$-10.50	$-41.56	$-1.80	$-2.10	$-4.20	$0.90	$-1.50	$1.80	$6.91	$3.60	$-4.80	$1.20	—	$-4.20	$-2.70	$-7.51	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.83	—	$-0.65	$-0.77	$-0.93	—	—	—	$-3.05	—	—	—	$-1.74	—	—	—	$-2.98	—	$-2.84	—	—	—	$18.63	$-3.73	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-5.19	$-4.85	$-1.38	$-0.10	$-0.84	$-0.26	$0.03	$-5.69	$-21.18	$-81.55	$11.70	$12.81	$14.60	$18.41	$16.66	$17.62	$13.46	—	$-4.88	$-1.10	$-5.20	—	$-2.10	$-4.05	$-3.02	—	—	—	—	$-7.24	—	—	$69.64	—	$88.34	$106.45	$66.51	—	—	—
Tangible Book Value per Share (USD)	$-6.88	$-6.70	$-3.23	$-1.95	$-2.70	$-2.13	$-1.98	$-8.40	$-29.91	$-90.47	$11.70	$12.81	$14.60	$18.41	$16.66	$17.62	$13.46	—	$-4.88	$-1.10	$-5.20	—	$-2.10	$-4.05	$-3.02	—	—	—	—	$-7.24	—	—	$69.64	—	$88.34	$106.45	$66.51	—	—	—
Basic Weighted Avg Shares (shares)	26.86M	—	26.00M	25.98M	25.90M	—	21.47M	16.72M	5.41M	—	5.15M	5.11M	5.11M	—	5.09M	4.95M	4.14M	—	3.84M	3.78M	—	—	3.51M	3.22M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Mar 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2014 10-K ↗	Q1 FY2016 Dec 31, 2014 10-K ↗	Q4 FY2015 Dec 31, 2013 10-K ↗
Working Capital (USD)	$106.09M	$114.34M	$133.46M	$151.14M	$170.12M	$193.65M	$207.73M	$98.67M	$74.45M	$22.52M	$69.93M	$93.36M	$111.86M	$123.06M	$135.95M	$138.81M	$90.76M	—	—	$79.52M	$78.52M	—	—	—	$44.37M	—	—	—	—	$6.93M	—	—	$87.71M	—	$96.03M	$94.53M	$58.18M	—	—	—
Total Equity (USD)	$-148.12M	$-126.24M	$-35.84M	$-2.53M	$-21.79M	$-6.80M	$752.00K	$-101.46M	$-116.80M	$-440.18M	$60.33M	$65.45M	$74.58M	$93.83M	$84.91M	$89.61M	$55.76M	$22.52M	$-18.73M	$-4.22M	$-19.57M	$-18.01M	$-7.38M	$-13.05M	$-8.76M	$8.40M	—	—	—	$-5.42M	$7.40M	$21.66M	$51.81M	—	$65.08M	$78.18M	$41.09M	$-87.75M	$-87.75M	$-69.46M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Mar 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2014 10-K ↗	Q1 FY2016 Dec 31, 2014 10-K ↗	Q4 FY2015 Dec 31, 2013 10-K ↗
Sales/Revenue/Turnover (USD)	$78.00K	$947.00K	$452.00K	$298.00K	$1.10M	$-759.00K	$387.00K	$33.45M	$5.84M	$8.27M	$6.55M	$5.25M	$5.94M	$16.80M	$20.71M	$39.27M	$34.00M	$29.94M	$24.43M	$19.66M	$11.05M	$11.95M	$4.65M	$0.00	$0.00	$6.65M	$0.00	$13.00K	$10.00K	$17.00K	$0.00	$0.00	$0.00	$137.00K	$27.00K	$26.00K	$137.00K	—	—	—
Depreciation Expense (USD)	$600.00K	$600.00K	$600.00K	$600.00K	$600.00K	$500.00K	$300.00K	$200.00K	$200.00K	$200.00K	$100.00K	$200.00K	$200.00K	$200.00K	$200.00K	$200.00K	$100.00K	$200.00K	$100.00K	$200.00K	$100.00K	$100.00K	$100.00K	$200.00K	$231.00K	$178.00K	$200.00K	$200.00K	$181.00K	$13.00K	$200.00K	$400.00K	$169.00K	$477.00K	$200.00K	$200.00K	$175.00K	—	—	—
Net Income, GAAP (USD)	$-39.18M	$-92.58M	$-17.71M	$-17.71M	$-17.71M	$-10.25M	$-56.82M	$-56.82M	$-56.82M	$-177.66M	$-21.66M	$-21.66M	$-21.66M	$5.89M	$28.78M	$28.78M	$28.78M	$12.24M	$-24.60M	$-24.60M	$-24.60M	$-15.45M	$-19.62M	$-19.62M	$-19.62M	$-14.89M	$-12.07M	$-12.07M	$-12.07M	$-19.54M	$-15.89M	$-15.89M	$-15.89M	$-15.13M	$-14.68M	$-15.97M	$-15.13M	—	—	—
Operating Cash Flow (USD)	$-22.14M	$-17.71M	$-15.60M	$-17.52M	$-23.11M	$-7.00M	—	—	$-15.92M	$-23.29M	—	—	$-8.77M	$-11.85M	—	—	$-11.86M	$-31.46M	$-10.75M	—	$-12.13M	$-7.25M	$65.64M	$-11.81M	$-11.70M	$-12.88M	$-11.12M	$-7.20M	$-20.24M	$26.66M	$-16.03M	$-16.97M	$-13.41M	$16.90M	—	—	$-15.32M	—	—	—

Cartesian Therapeutics, Inc.

Analytical Summary

40-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare RNAC with peers